Skip to main content
Clinical Trials/NCT04928989
NCT04928989
Withdrawn
Not Applicable

What Does Web-based Neck-specific Exercise Add to a Digital Convergence Dialogue Meeting Promoting the Work Situation for Employees With Neck Pain?

Linkoeping University2 sites in 1 countryMay 2022
ConditionsWorkplace

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Workplace
Sponsor
Linkoeping University
Locations
2
Primary Endpoint
Work Ability Score
Status
Withdrawn
Last Updated
3 years ago

Overview

Brief Summary

The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to convergenge dialogue meeting with or without neck-specific exercise. The main outcome measure is work ability, measured via the Work Ability Score.

Detailed Description

Background: Collaboration between employees, manager and occupational health expert is needed to promote work ability. One effective method is a convergence dialogue meeting (CDM). Based on the existing work situation, factors are identified in these meetings that can strengthen the employee's work ability and opportunities for a sustainable working life. A combination of workplace and individual interventions is recommended for best effect. Neck-specific exercise (NSE) is the method with the most evidence for neck problems. NSE in evidence based form has not been investigated for work-related neck pain. More knowledge is needed regarding how CDM can be combined with NSE because clear guidelines are lacking on the best intervention for increased work ability in the case of neck problems. Also lacking are evaluations of digitally distributed CDMs and NSE with support from a web-based program for the current population. The aim of the proposed randomized controlled study is to investigate the contribution of NSE with four visits to a physiotherapist and support from a web-program in addition to three digital CDMs promoting the work situation. Methods: The study will be conducted at workplaces, where the work environment and tasks increase employee risk of developing neck problems. A total of 320 participants will be recruited consecutively and after informed consent randomized to CDM with or without NSE. The main outcome measure is work ability, measured via the Work Ability Score. Secondary outcome measures are pain, function, health-related quality of life, work absenteeism and presenteeism, work-related factors, and cost-effectiveness. Pathophysiological aspects regarding inflammation and stress markers measured in blood and saliva will be studied, as will muscular changes measured by microdialysis. Interviews are planned with both employees and managers. Discussion: The goal of the study is to contribute to improved rehabilitation, strengthened work ability, and a sustainable working life for employees with neck problems.

Registry
clinicaltrials.gov
Start Date
May 2022
End Date
December 2026
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Linkoeping University
Responsible Party
Principal Investigator
Principal Investigator

Anneli Peolsson

Professor, PhD, MSc PT, MSc HRMD

Linkoeping University

Eligibility Criteria

Inclusion Criteria

  • Self-reported neck problems that the person experiences as troublesome, affecting ability to perform work, and lasting at least 4 weeks.
  • Neck problems as being predominant.
  • Current neck pain ≥ 3 on the numeric rating scale (0-10) \[53, 55\].
  • Persons of working age, 18-65 years, who have a permanent job.
  • Neck problems clinically verified through a clinical examination to ensure study criteria are met.
  • Answers the baseline questionnaire and attends the first intervention visit.
  • Confirms being motivated to participate and completes and signs informed consent, including approval, to contact their immediate supervisor regarding a CDM.

Exclusion Criteria

  • Red flags and illness/injury that are contraindicated for or hinder exercise or may be confounding factors for the results, such as severe cardiovascular/lung disease, malignancy, severe rheumatic disease, severe neurological disease, spinal cord injury, diagnosed severe mental illness, drug or alcohol abuse, neck surgery, neck fracture or dislocation, severe cervical radiculopathy, myelopathy, general body pain (e.g., fibromyalgia, Ehlers-Danlos syndrome, generalized osteoarthritis).
  • Known pregnancy.
  • Cannot understand/communicate in Swedish and thus would be unable to understand information in the study.
  • For blood samples (not wanting to participate does not constitute exclusion for the randomized controlled trial), the following exclusion criteria are added: increased tendency to bleed and use of blood thinners.
  • For the subgroup for microdialysis (n = 30, consecutively asked, 15 persons/group; not wanting to participate does not constitute exclusion for the randomized controlled trial), the following exclusion criteria are added:
  • Patients who cannot imagine refraining from non-steroid anti-inflammatory drugsduring 2 days before microdialysis may not participate in the microdialysis part of the study.
  • Hypersensitivity to anesthetic and antibiotics.
  • Increased tendency to bleed and use of blood-thinning drugs.

Outcomes

Primary Outcomes

Work Ability Score

Time Frame: Change in work Ability Score from baseline, to every month until the 15 month follow-up

Current work ability compared to when it was at its best

Secondary Outcomes

  • Neck specific function(change from baseline to 3 month and 15 month follow-up)
  • Exercise/physical activity level(change from baseline to 3 month and 15 month follow-up)
  • Time sitting(change from baseline to 3 month and 15 month)
  • Intensity of pain and bothersomeness(change from baseline to 3 month and 15 month follow-up)
  • Health related quality of life(change from baseline to 3 month and 15 month follow-up)
  • self rated function(change from baseline to 3 month follow-up)
  • Work ability(change from baseline to 3 month and 15 month follow-up)
  • Presenteeism(change from baseline to 3 month and 15 month follow-up)
  • Demand-control, support(change from baseline to 3 month and 15 month follow-up)
  • Frequency of pain, symtoms and medications(change from baseline to 3 month and 15 month follow-up)
  • Symptom satisfaction(change from baseline to 3 month and 15 month follow-up)
  • self-rated work situation regarding working hours(description and change from baseline to 3 month and 15 month follow-up)
  • perceived exertion at work(change from baseline to 3 month and 15 month follow-up)
  • Risk identifaction at work(change from baseline to 3 month and 15 month follow-up)
  • Fulfilment of treatment expectation(3 month and 15 month related to the patient own expectations)
  • Adverse events/ side-effects(3 month, 15 month)
  • Cost-effectiveness(From the time period between baseline to 15 month follow-up)
  • Interview with managers(3 month, approximately n=20)
  • self-rated work situation regarding satisfaction at work(description and change from baseline to 3 month and 15 month follow-up)
  • Fear avoidance(change from baseline to 3 month and 15 month follow-up)
  • work situation(description and change from baseline to 3 month and 15 month follow-up)
  • work adaptation(change from baseline to 3 month and 15 month follow-up)
  • Anxiety and depression(change from baseline to 3 month and 15 month follow-up)
  • self-rated work situation regarding self-rated work performance(description and change from baseline to 3 month and 15 month follow-up)
  • self-rated work situation regarding neck position at work(description and change from baseline to 3 month and 15 month follow-up)
  • Sick leave,(change from baseline to 3 month and 15 month follow-up)
  • Effort-Reward Imbalance(change from baseline to 3 month and 15 month follow-up)
  • Satisfaction with the caregiver visits in the study(3 month, 15 month)
  • Microdialysis, tissue changes in the middle Trapezius(baseline, 3 month, subgroup of the RCT population approximately n=30)
  • Health related quality of life on vertical visual analogue scale(change from baseline to 3 month and 15 month follow-up)
  • self-rated work situation regarding work environment(description and change from baseline to 3 month and 15 month follow-up)
  • Overall outcome(change from baseline to follw-ups at 3 month and 15 month)
  • Interview study of employers(3 month, subgroup of the RCT population, n=20 approximately)
  • Saliva samples and blood samples(change from baseline to 3 month in a subgroup of the RCT population, all those who agree and are without contra indication)
  • Observation study(During the 3 month treatment period at tripartiate convergence dialogue meeting)
  • self-rated work situation regarding stress at work(description and change from baseline to 3 month and 15 month follow-up)

Study Sites (2)

Loading locations...

Similar Trials